Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms, Glandular and Epithelial 1Neoplasms 1

Interventions

entinostat 2Gemcitabine 2pembrolizumab 1napabucasin 1interferon gamma-1b 1VB6-845 fusion protein 1Taxes 1Paclitaxel 1Oncolytic Virotherapy 1Nivolumab 1Leucovorin 1Irinotecan 1Interferon-gamma 1Immunotherapy 1Fluorouracil 1Cobicistat 1Cell Count 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms, Glandular and Epithelial × VB6-845 fusion protein × Clear all
NCT00481936 2023-03-23

Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin

Sesen Bio, Inc.

Phase 1 Terminated
15 enrolled

Neoplasms, Neoplasms, Glandular and Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡